Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients

Addictive Behaviors

Volumn 72, Issue , 2017, Pages 14-20

  Haug, Nancy A ^a,b   Padula, Claudia B ^b,c   Sottile, James E ^a   Vandrey, Ryan ^d   Heinz, Adrienne J ^c   Bonn Miller, Marcel O ^e,f,g  

^a PALO ALTO UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g Zynerba Pharmaceuticals Inc   (United States)

Author keywords

Age; Cannabis; Marijuana; Medical; Motives

Indexed keywords

MEDICAL CANNABIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALCOHOL CONSUMPTION; ANALYSIS OF VARIANCE; ARTICLE; CANNABIS USE; CHI SQUARE TEST; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GLAUCOMA; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MIDDLE AGED; YOUNG ADULT; ADOLESCENT; AGE; AMBULATORY CARE; CALIFORNIA; COMPARATIVE STUDY; COPING BEHAVIOR; EPIDEMIOLOGY; MENTAL DISEASE; MOTIVATION; ONSET AGE; PAIN; PSYCHOLOGY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AMBULATORY CARE; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MARIJUANA USE; MEDICAL MARIJUANA; MENTAL DISORDERS; MIDDLE AGED; MOTIVATION; PAIN; SAN FRANCISCO; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85015785424     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2017.03.006     Document Type: Article

References (47)

1. Adamson, S.J., Kay-Lambkin, F.J., Baker, A.L., Lewin, T.J., Thornton, L., Kelly, B.J., Sellman, J.D., An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug and Alcohol Dependence 110:1–2 (2010), 137–143.
2. Banes, K.E., Stephens, R.S., Blevins, C.E., Walker, D.D., Roffman, R.A., Changing motives for use: Outcomes from a cognitive-behavioral intervention for cannabis-dependent adults. Drug and Alcohol Dependence 139 (2014), 41–46, 10.1016/j.drugalcdep.2014.02.706.
3. Benschop, A., Liebregts, N., van der Pol, P., Schaap, R., Buisman, R., van Laar, M.,.. Korf, D.J., Reliability and validity of the marijuana motives measure among young adult frequent cannabis users and associations with cannabis dependence. Addictive Behaviors 40 (2015), 91–95.
4. Bloor, R.N., Wang, T.S., Spanel, P., Smith, D., Ammonia release from heated ‘street’ cannabis leaf and its potential toxic effects on cannabis users. Addiction 103:10 (2008), 1671–1677.
5. Bonn-Miller, M.O., Boden, M.T., Bucossi, M.M., Babson, K.A., Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. The American Journal of Drug and Alcohol Abuse 40:1 (2014), 23–30, 10.3109/00952990.2013.821477.
6. Bonn-Miller, M.O., Zvolensky, M.J., An evaluation of the nature of cannabis use and its motives among young adult active users. The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions 18:5 (2009), 409–416, 10.3109/10550490903077705.
7. Brennan, P.L., Nichol, A.C., Moos, R.H., Older and younger patients with substance use disorders: Outpatient mental health service use and functioning over a 12-month interval. Psychology of Addictive Behaviors 17:1 (2003), 42–48, 10.1037/0893-164X.17.1.42.
8. Bruno, R., Marshall, S., Adamson, S., Screening for DSM-5 cannabis dependence using the Cannabis Use Identification Test-Revised (CUDIT-R). Poster Presented at the Australasian Professional Society on Alcohol and other Drugs. Brisbane, Australia, 2013, Nov.
9. Cerda, M., Wall, M., Keyes, K.M., Galea, S., Hasin, D., Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug and Alcohol Dependence 120 (2012), 22–27.
10. Chen, K., Kandel, D.B., The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health 85:1 (1995), 41–47, 10.2105/AJPH.85.1.41.
11. Cohen, N.L., Heinz, A.J., Ilgen, M., Bonn-Miller, M.O., Pain, cannabis species, and addiction. Journal of Studies on Alcohol and Drugs 77:3 (2016), 515–520.
12. Compton, W.M., Han, B., Hughes, A., Jones, C.M., Blanco, C., Use of marijuana for medical purposes among adults in the United States. JAMA: Journal Of The American Medical Association 317:2 (2017), 209–211, 10.1001/jama.2016.18900.
13. Delforterie, M.J., Creemers, H.E., Agrawal, A., Lynskey, M.T., Jak, S., Huizink, A.C., The influence of age and gender on the likelihood of endorsing cannabis abuse/dependence criteria. Addictive Behaviors 42 (2015), 172–175.
14. DeWit, D.J., Hance, J., Offord, D.R., Ogborne, A., The influence of early and frequent use of marijuana on the risk of desistance and of progression to marijuana-related harm. Preventive Medicine: An International Journal Devoted to Practice and Theory 31:5 (2000), 455–464, 10.1006/pmed.2000.0738.
15. DiNitto, D.M., Choi, N.G., Cannabis use among older adults in the U.S.A.: User characteristics, patterns of use, and implications for intervention. International Psychogeriatrics 23:5 (2011), 732–741, 10.1017/S1041610210002176.
16. Edinger, J.D., Wohlgemuth, W.K., Radtke, R.A., Marsh, G.R., Quillian, R.E., Cognitive behavioral therapy for treatment of chronic primary insomnia: A randomized controlled trial. Journal of the American Medical Association 285:14 (2001), 1856–1864.
17. Fox, C.L., Towe, S.L., Stephens, R.S., Walker, D.D., Roffman, R.A., Motives for cannabis use in high-risk adolescent users. Psychology of Addictive Behaviors 25:3 (2011), 492–500, 10.1037/a0024331.
18. Furler, M.D., Einarson, T.R., Millson, M., Walmsley, S., Bendayan, R., Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care and STDs 18:4 (2004), 215–228, 10.1089/108729104323038892.
19. Gieringer, D.H., Cannabis “vaporization”: A promising strategy for smoke harm reduction. Journal of Cannabis Therapeutics 1:3/4 (2001), 153–170.
20. Gruber, S.A., Silveri, M.M., Dahlgren, M.K., Yurgelun-Todd, D., Why so impulsive? White matter alterations are associated with impulsivity in chronic cannabis smokers. Experimental and Clinical Psychopharmacology 19:3 (2011), 231–242, 10.1037/a0023034.
21. Hasin, D.S., Wall, M., Keyes, K.M., Cerdá, M., Schulenberg, J., O'Malley, P.M.,.. Feng, T., Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: Results from annual, repeated cross-sectional surveys. Lancet Psychiatry 2 (2015), 601–608.
22. Hiles, M., Walsh, Z., Corsby, K., Swogger, M.T., Cannabis use motives and frequency of use: Combined and distinct associations with cannabis use problems. Drug and Alcohol Dependence 140 (2014), E88–E89.
23. Ilgen, M.A., Bohnert, K., Kleinberg, F., Jannausch, M., Bohnert, A.S.B., Walton, M., Blow, F., Characteristics of adults seeking medical marijuana certification. Drug and Alcohol Dependence 132:3 (2013), 654–659.
24. Jensen, M., Turner, J., Romano, J., Fisher, L., Comparative reliability and validity of chronic pain intensity measures. Pain 83 (1999), 157–162.
25. LaRose, R., Lin, C.A., Easton, M.S., Unregulated internet usage: Addiction, habit or self-regulation?. Media Psychology 5 (2003), 225–253.
26. Lee, C.M., Neighbors, C., Hendershot, C.S., Grossbard, J.R., Development and preliminary validation of a comprehensive cannabis motives questionnaire. Journal of Studies on Alcohol and Drugs 70:2 (2009), 279–287.
27. Lopez-Larson, M.P., Bogorodzki, P., Rogowska, J., McGlade, E., King, J.B., Terry, J., Yurgelun-Todd, D., Altered prefrontal and insular cortical thickness in adolescent cannabis users. Behavioural Brain Research 220:1 (2011), 164–172, 10.1016/j.bbr.2011.02.001.
28. Martins, S.S., Mauro, C.M., Santaella-Tenorio, J., Kim, J.H., Cerda, M., Keyes, K.M.,.. Wall, M., State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population. Drug And Alcohol Dependence 169 (2016), 26–32, 10.1016/j.drugalcdep.2016.10.004.
29. Mitchell, H., Zvolensky, M.J., Marshall, E.C., Bonn-Miller, M.O., Vujanovic, A.A., Incremental validity of coping-oriented cannabis use motives in the prediction of affect-based psychological vulnerability. Journal of Psychopathology and Behavioral Assessment 29:4 (2007), 277–288, 10.1007/s10862-007-9047-z.
30. Murphy, J.G., Correia, C.J., Colby, S.M., Vuchinich, R.E., Using behavioral theories of choice to predict drinking outcomes following a brief intervention. Experimental and Clinical Psychopharmacology 13:2 (2005), 93–101.
31. National Conference of State Legislatures, State medical cannabis laws. Retrieved from: http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx, 2017.
32. Ogborne, A.C., Smart, R.G., Weber, T., Birchmore-Timney, C., Who is using cannabis as a medicine and why: An exploratory study. Journal of Psychoactive Drugs 32:4 (2000), 435–443, 10.1080/02791072.2000.10400245.
33. Pacula, R.L., Powell, D., Heaton, P., Sevigny, E.L., Assessing the effects of medical cannabis laws on cannabis use: The devil is in the details. Journal of Policy Analysis and Management 34:1 (2015), 7–31, 10.1002/pam.21804.
34. Plunk, A.D., Agrawal, A., Harrell, P.T., Tate, W.F., Will, K.E., Mellor, J.M., Grucza, R.A., The impact of adolescent exposure to medical marijuana laws on high school completion, college enrollment and college degree completion. Drug & Alcohol Dependence 168 (2016), 320–327, 10.1016/j.drugalcdep.2016.09.002.
35. Price, R.K., Risk, N.K., Spitznagel, E.L., Remission from drug abuse over a 25-year period: Patterns of remission and treatment use. American Journal of Public Health 91:7 (2001), 1107–1113, 10.2105/AJPH.91.7.1107.
36. Reinarman, C., Nunberg, H., Lanthier, F., Heddleston, T., Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of Psychoactive Drugs 43:2 (2011), 128–135.
37. Roy-Byrne, P., Maynard, C., Bumgardner, K., Krupski, A., Dunn, C., West, I.I.,.. Ries, R., Are medical marijuana users different from recreational users? The view from primary care. The American Journal On Addictions/American Academy Of Psychiatrists In Alcoholism And Addictions 24:7 (2015), 599–606, 10.1111/ajad.12270.
38. Ryan-Ibarra, S., Induni, M., Ewing, D., Prevalence of medical marijuana use in California, 2012. Drug and Alcohol Review 34:2 (2015), 141–146, 10.1111/dar.12207.
39. SAMHSA Center for Behavioral Health Statistics and Quality, The NSDUH report: Illicit drug use among older adults. Rockville, MD. Retrieved from: http://oas.samhsa.gov/2k11/013/WEB_SR_013_HTML.pdf, 2011.
40. Saunders, J.B., Aasland, O.G., Babor, T.F., la Fuente, De, Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption - II. Addiction 88 (1993), 791–804.
41. Schneider, K.M., O'Donnell, B.E., Dean, D., Prevalence of multiple chronic conditions in the United States' Medicare population. Health Quality Life Outcomes, 7, 2009, 82, 10.1186/1477-7525-7-82.
42. Sepehrmanesh, Z., Ahmadvand, A., Ghoreishi, F., PW01-111 - prevalence of insomnia in general population. European Psychiatry, 251524, 2010, 10.1016/S0924-9338(10)71507-8.
43. Simons, J., Correia, C.J., Carey, K.B., Borsari, B.E., Validating a five-factor cannabis motives measure: Relations with use, problems, and alcohol motives. Journal of Counseling Psychology 45:3 (1998), 265–273, 10.1037/0022-0167.45.3.26.
44. Substance Abuse and Mental Health Services Administration, Results from the 2008 national survey on drug use and health: National findings. Office of Applied Studies, NSDUH series H-36, HHS publication no. SMA 09–4434. 2009, U.S. Department of Health and Human Services, Rockville, MD.
45. Watson, D., O'Hara, M., Simms, L., Kotoc, R., Chmieleski, M., McDade-Montez, E.,.. Stuart, S., Development and validation of the inventory of depression and anxiety symptoms (IDAS). Psychological Assessment 19 (2007), 253–268.
46. Wen, H., Hockenberry, J.M., Cummings, J.R., The effect of medical cannabis laws on adolescent and adult use of cannabis, alcohol, and other substances. Journal of Health Economics 42 (2015), 64–80, 10.1016/j.jhealeco.2015.03.007.
47. Woodruff, S.I., Shillington, A.M., Sociodemographic and drug use severity differences between medical marijuana users and non-medical users visiting the emergency department. The American Journal on Addictions/American Academy of Psychiatrists In Alcoholism And Addictions 25:5 (2016), 385–391, 10.1111/ajad.12401.